Interleukin-6 added to CALL score better predicts the prognosis of COVID-19 patients
Intern Med J
.
2021 Jan;51(1):146-147.
doi: 10.1111/imj.14974.
Epub 2020 Dec 18.
Authors
Elisa Grifoni
1
,
Vieri Vannucchi
2
,
Alice Valoriani
3
,
Francesco Cei
3
,
Roberta Lamanna
4
,
Anna Maria Grazia Gelli
4
,
Benedetta Ciambotti
4
,
Federico Moroni
2
,
Lorenzo Pelagatti
2
,
Roberto Tarquini
3
,
Giancarlo Landini
2
,
Simone Vanni
5
,
Luca Masotti
1
Affiliations
1
Internal Medicine II, San Giuseppe Hospital, Empoli, Italy.
2
Internal Medicine, Santa, Maria Nuova Hospital, Florence, Italy.
3
Internal Medicine I, San Giuseppe Hospital, Empoli, Italy.
4
Clinical Pathology, Laboratory Department, San Giuseppe Hospital, Empoli, Italy.
5
Emergency Department, San Giuseppe Hospital, Empoli, Italy.
PMID:
33336833
DOI:
10.1111/imj.14974
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Disease Progression
Humans
Interleukin-6*
Prognosis
SARS-CoV-2
Substances
Interleukin-6